Prehospital Provider Training With Augmented Reality (AR)

Sponsor
Thomas Caruso (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05686590
Collaborator
(none)
30
2
1
12
15
1.3

Study Details

Study Description

Brief Summary

The goal is to evaluate the acceptance of Augmented Reality (AR) simulation as a learning modality for prehospital providers. The simulation itself is grounded in traditional best practices for simulation delivery and design as well as prior literature on simulation training for prehospital providers; the focus of this study is the participants' experiential interaction with AR and the simulation resources.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Augmented Reality Headset
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Prehospital Provider Training Using Augmented Reality Simulation: A Mixed-Methods Study
Actual Study Start Date :
Dec 12, 2022
Anticipated Primary Completion Date :
Dec 12, 2023
Anticipated Study Completion Date :
Dec 12, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Augmented Reality Enhanced Simulation (Treatment group)

Each simulation will have between two and five participants. After consent, demographic data will be collected. Then, a study RA will fit a Magic Leap One (ML1) headsets (Magic Leap Inc., Plantation, FL) to participants. Following a scripted briefing, the instructor will also orient the participants to the ML1 headset for those in that group. After orienting the participant to the use of the headsets, the instructor will remain in a room separate from the participants, who will conduct the scenario outside. This will enable assessment of the feasibility of providing simulation instruction remotely. Prior to starting the scenario, the simulation instructor will conduct an orientation to review the core tenets of effective communication skills during prehospital care.

Behavioral: Augmented Reality Headset
The simulation scenario will be a pediatric hypoglycemia-induced seizure case, which will be done through an AR simulation. AR (Augmented Reality) headset, which is a device that the participants will wear over their head and eyes and will add holographic elements to a live view of workplace training scenario.

Outcome Measures

Primary Outcome Measures

  1. Thematic Analysis of Post-Simulation Discussions [Duration of post-simulation debrief (15-20 minutes)]

    The primary aim is to study the acceptance of AR simulation amongst prehospital providers via thematic analysis of semi-structured discussions using qualitative research methods.

Secondary Outcome Measures

  1. System Usability Scale (SUS) [Duration of Intervention (less than one hour)]

    The first secondary aim is to evaluate AR simulation usability amongst prehospital providers via the System Usability Scale (SUS).

  2. Headset Ergonomics [Duration of Intervention (less than one hour)]

    The final secondary aim will evaluate the ergonomics of the headset via the ISO 9241-400 assessment of human-ergonomic factors.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Trainees/ faculty working and/or volunteering at LPCH/SHC facilities as well as community based prehospital providers

  • 18 years and older

Exclusion Criteria:
  • Participants who do not consent

  • Have a history of severe motion sickness

  • Currently have nausea

  • History of seizures

  • Are clinically unstable

  • Currently using corrective glasses (not compatible with AR headset)

  • Currently pregnant

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mountain View Fire Department Mountain View California United States 94041
2 Lucile Packard Children's Hospital at Stanford Palo Alto California United States 94305

Sponsors and Collaborators

  • Thomas Caruso

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Thomas Caruso, Clinical Professor, Stanford University
ClinicalTrials.gov Identifier:
NCT05686590
Other Study ID Numbers:
  • 67544
First Posted:
Jan 17, 2023
Last Update Posted:
Jan 17, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 17, 2023